Physician profile
Mohammed Haseebuddin
NPI 1174750970
$6,319.88
in general payments reported to CMS, 2019-2025
45 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $628 · 2021: $1,092 · 2022: $840 · 2023: $1,539 · 2024: $760 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,334.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,061.64 | 2023-2025 | Gemtesa, Orgovyx |
| Dornier Medtech America, INC | $556.34 | 2023 | Dornier Medtech |
| Urogen Pharma, INC. | $534.45 | 2020-2025 | Jelmyto |
| Astellas Pharma US INC | $490.76 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $439.03 | 2021-2025 | |
| Pfizer INC. | $280.91 | 2019-2025 | |
| Boston Scientific Corporation | $251.55 | 2019-2025 | Spaceoar Vue System - 10ml, General - Erectile Dysfunction |
| Coloplast Corp | $230.08 | 2019-2025 | |
| Janssen Biotech, INC. | $169.90 | 2019-2025 | Erleada |
| Urovant Sciences INC | $160.33 | 2021-2022 | |
| Calyxo, INC. | $158.55 | 2024-2025 | Cvac Aspiration System |
| Ethicon US, LLC | $148.62 | 2020-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Stratafix |
| Tolmar Pharmaceuticals, INC. | $133.23 | 2021-2022 | |
| Baxter Healthcare | $121.95 | 2019 | |
| Antares Pharma, INC. | $107.59 | 2022-2025 | Xyosted, Nocdurna, Tlando |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $105.76 | 2023 | Axonics |
| Endo Pharmaceuticals INC. | $94.43 | 2019-2021 | |
| Teleflex LLC | $92.33 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $90.77 | 2020-2024 | Lynparza, Keytruda |
| Laborie Medical Technologies Corp. | $81.23 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $68.25 | 2022-2023 | Itind System |
| Procept Biorobotics Corporation | $68.11 | 2021-2024 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $63.10 | 2020-2023 | |
| Medtronic, INC. | $62.49 | 2022-2023 | Interstim |
| Dendreon Pharmaceuticals LLC | $57.70 | 2020-2021 | |
| Becton, Dickinson and Company | $55.83 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Myovant Sciences INC. | $54.76 | 2021 | |
| Valencia Technologies Corporation | $47.41 | 2022-2025 | Ecoin Device Kit |
| Blue Earth Diagnostics | $46.86 | 2020-2022 | |
| Progenics Pharmaceuticals, INC. | $45.91 | 2024 | |
| Novartis Pharmaceuticals Corporation | $44.66 | 2022-2025 | |
| Tempus Ai, INC | $43.79 | 2024 | |
| Tolmar, INC. | $42.93 | 2023-2024 | |
| Azurity Pharmaceuticals, INC. | $36.76 | 2025 | Azmiro |
| Neotract INC. | $35.95 | 2020 | |
| Halozyme INC | $33.90 | 2023 | |
| Immunitybio, INC. | $29.58 | 2025 | |
| Alnylam Pharmaceuticals INC. | $28.77 | 2023 | Givlaari |
| Myriad Genetic Laboratories, INC. | $26.19 | 2020 | |
| Dentsply Ih INC. | $24.57 | 2021 | |
| Novo Nordisk INC | $24.33 | 2024 | Rivfloza |
| Photocure INC | $21.18 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.09 | 2023 | Exparel |
| 180 Medical, INC. | $16.21 | 2022 | |
| Hollister Incorporated | $14.10 | 2023 | Vapro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Haseebuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.